Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
123
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Tuberculosis 2017 NICHD 5R01HD074944-03 Innovative PK/PD Approaches to Optimize TBM Treatment in Children (PATCH Study) DOOLEY, KELLY JOHNS HOPKINS UNIVERSITY MD $500,491
Tuberculosis 2017 NHLBI 5R01HL129887-02 Anti-TB sterilizing immunity in immune and HIV+ individuals CHEN, ZHENG UNIVERSITY OF ILLINOIS AT CHICAGO IL $674,207
Tuberculosis 2017 NIBIB 5R01EB021900-02 SCH: INT A.Soclotechnilcal Systems Systems Approach for Improving Tuberculosis Diagnostics Using Mobile Health Technologies BRUNETTE, MARIA UNIVERSITY OF MASSACHUSETTS LOWELL MA $326,571
Tuberculosis 2017 NIAID 5R01AI115471-03 Gamma Delta T cell surveillance of metabolites as signals of cellular stress ADAMS, ERIN UNIVERSITY OF CHICAGO IL $389,432
Tuberculosis 2017 NIAID 5UM1AI069415-12 Integrated University of Puerto Rico Clinical Trials Unit ZORRILLA, CARMEN UNIVERSITY OF PUERTO RICO MED SCIENCES PR $1,139,676
Tuberculosis 2017 NIAID 5UM1AI069501-11 Case Clinical Trials Unit LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $1,874,344
Tuberculosis 2017 OD 5UM1AI069501-11 Case Clinical Trials Unit LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $103,025
Tuberculosis 2017 NIAID 5R01AI121354-02 The necrosis-inducing toxin of Mycobacterium tuberculosis NIEDERWEIS, MICHAEL UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $534,163
Tuberculosis 2017 NIAID 5UM1AI069432-11 The UCSD CD4 Collaborative Clinical Trial Unit BENSON, CONSTANCE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,370,023
Tuberculosis 2017 NIAID 5UM1AI069439-12 Vanderbilt HIV Clinical Trials Unit HAAS, DAVID VANDERBILT UNIVERSITY MEDICAL CENTER TN $1,003,759
Tuberculosis 2017 FIC 5T37MD001424-13 Tulane Xavier Minority Training in International Health OBERHELMAN, RICHARD TULANE UNIVERSITY OF LOUISIANA LA $1,000
Tuberculosis 2017 NIMHD 5T37MD001424-13 Tulane Xavier Minority Training in International Health OBERHELMAN, RICHARD TULANE UNIVERSITY OF LOUISIANA LA $136,818
Tuberculosis 2017 NIAID 5UM1AI069412-11 Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU) DOLIN, RAPHAEL BETH ISRAEL DEACONESS MEDICAL CENTER MA $3,046,726
Tuberculosis 2017 NIAID 5UM1AI069494-11 PItt-Ohio State-Georgetown Clinical Trials Unit MELLORS, JOHN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $1,491,683
Tuberculosis 2017 NIAID 5UM1AI069496-11 San Francisco Bay Clinical Trials Unit BUCHBINDER, SUSAN PUBLIC HEALTH FOUNDATION ENTERPRISES CA $1,490,310
Tuberculosis 2017 NIAID 5R01AI104488-04 A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection Outcomes FARLEY, JASON JOHNS HOPKINS UNIVERSITY MD $616,042
Tuberculosis 2017 NIAID 5UM1AI069421-11 GHESKIO HIV Clinical Trial Unit PAPE, JEAN GHESKIO CENTER HAITI $1,030,670
Tuberculosis 2017 NIAID 5UM1AI068634-11 Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG) HUGHES, MICHAEL HARVARD SCHOOL OF PUBLIC HEALTH MA $13,641,027
Tuberculosis 2017 NIAID 5UM1AI069465-11 The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU) FLEXNER, CHARLES JOHNS HOPKINS UNIVERSITY MD $1,987,063
Tuberculosis 2017 NIAID 5UM1AI069476-10 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $74,365
Tuberculosis 2017 NIAID 5UM1AI069422-11 South African Medical Research Council Clinical Trials Unit (MRC CTU) RAMJEE, GITA MEDICAL RESEARCH COUNCIL OF SOUTH AFRICA SO AFR $1,084,670
Tuberculosis 2017 NIAID 5UM1AI069519-11 University of Cape Town Clinical Trials Unit (UCTCTU) BEKKER, LINDA-GAIL UNIVERSITY OF CAPE TOWN SO AFR $1,749,653
Tuberculosis 2017 NIAID 5UM1AI069418-11 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,403,962
Tuberculosis 2017 NIAID 5R01AI118224-02 Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis TAN, DEREK SLOAN-KETTERING INST CAN RESEARCH NY $666,740
Tuberculosis 2017 NIAID 5UM1AI069469-11 CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment ABDOOL KARIM, QUARRAISHA CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA SO AFR $1,311,319
Tuberculosis 2017 NIAID 5UM1AI069521-11 Stellenbosch University Clinical Trials Unit (SUN-CTU) COTTON, MARK STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS SO AFR $1,287,739
Tuberculosis 2017 NIAID 5UM1AI069503-11 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $4,875,952
Tuberculosis 2017 NIAID 5UM1AI069438-11 IMPACTA PERU CLINICAL TRIALS UNIT LAMA, JAVIER ASOCIACION CIVIL IMPACTA SALUD Y EDUCACN PERU $1,691,063
Tuberculosis 2017 NIAID 5UM1AI106701-04 Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3 COOMBS, ROBERT BRIGHAM AND WOMEN'S HOSPITAL MA $6,624,131
Tuberculosis 2017 NIAID 5UM1AI069453-11 KARABELO Clinical Trials Unit for NIAID Networks GRAY, GLENDA WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $1,366,759
Tuberculosis 2017 NIAID 5UM1AI069463-11 Clinical Trials Units for NIAID Networks (UM1) SANNE, IAN WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $1,051,232
Tuberculosis 2017 NCI 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $100,000
Tuberculosis 2017 NIAID 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $49,153,075
Tuberculosis 2017 NIDA 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Tuberculosis 2017 NINDS 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Tuberculosis 2017 OD 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $2,899,810
Tuberculosis 2017 NIAID 5UM1AI069423-11 University of North Carolina Global HIV Prevention and Treatment Clinical Trials ERON, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $2,644,627
Tuberculosis 2017 NIAID 5R01AI037856-16 M.tb Survival Regulatory Genes BISHAI, WILLIAM JOHNS HOPKINS UNIVERSITY MD $521,301
Tuberculosis 2017 NIAID 5R01AI116605-02 Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation ABRAMOVITCH, ROBERT MICHIGAN STATE UNIVERSITY MI $380,779
Tuberculosis 2017 NIAID 5R01AI116787-03 Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa DOWDY, DAVID JOHNS HOPKINS UNIVERSITY MD $600,728
Tuberculosis 2017 NIAID 5R01AI119022-03 Structure and mechanism of the ESX secretion system from pathogenic mycobacteria KOROTKOV, KONSTANTIN UNIVERSITY OF KENTUCKY KY $376,250
Tuberculosis 2017 NIAID 5R21AI115302-02 Self-assembling Peptide Nanomaterials for Eliciting Mucosal CD8+ T cell Immunity RUDRA, JAI UNIVERSITY OF TEXAS MED BR GALVESTON TX $188,800
Tuberculosis 2017 NIAID 5R01AI114674-03 The Consequences of Reinfection with M. tuberculosis FLYNN, JOANNE UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $736,682
Tuberculosis 2017 NIAID 5R01AI051242-14 Cellular and Bacterial Dynamics in Tuberculosis ERNST, JOEL NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $577,349
Tuberculosis 2017 NIAID 5R21AI121805-02 Towards a new regimen to treat mycobacterial infection in cystic fibrosis patients LAMICHHANE, GYANU JOHNS HOPKINS UNIVERSITY MD $243,000
Tuberculosis 2017 NIAID 5U01AI115642-03 Natural Resistance to Mycobacterium Tuberculosis Infection BOOM, HENRY CASE WESTERN RESERVE UNIVERSITY OH $686,622
Tuberculosis 2017 NIAID 5R01AI111943-03 Perturbation of antigen-specific T cell responses in latent TB/SIV co-infection KAUSHAL, DEEPAK TULANE UNIVERSITY OF LOUISIANA LA $843,809
Tuberculosis 2017 NIAID 5R21AI121829-02 A new essential protein kinase in Mycobacterium tuberculosis GRUNDNER, CHRISTOPH SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $250,132
Tuberculosis 2017 NIAID 5R01AI114304-04 Safety, pharmacokinetics, and resistance to bedaquiline in XDR TB and HIV BRUST, JAMES ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $716,766
Tuberculosis 2017 NIAID 5R21AI121621-02 The in vivo effect of vitamin D on Mycobacterium tuberculosis infection SALGAME, PADMINI RBHS-NEW JERSEY MEDICAL SCHOOL NJ $189,878
Tuberculosis 2017 NIAID 5R01AI110780-03 Novel Structure-Based Rifamycins for Drug-resistant TB and HIV Co-infection GARCIA, GEORGE UNIVERSITY OF MICHIGAN MI $641,007
Tuberculosis 2017 NIAID 1R01AI122070-01A1 A Neonatal Monkey Model for Tuberculosis Vaccination JAGANNATH, CHINNASWAMY UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $903,746
Tuberculosis 2017 NIAID 5R01AI123024-02 Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection METCALFE, JOHN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $751,593
Tuberculosis 2017 NIAID 5R01AI076327-09 T regulatory cells and immunity in tuberculosis URDAHL, KEVIN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $547,983
Tuberculosis 2017 NIAID 5R01AI116039-03 Altered immune-endocrine axis in type 2 diabetes and tuberculosis risk RONACHER, KATHARINA STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS SO AFR $131,251
Tuberculosis 2017 NIAID 5R44AI122428-03 Novel therapeutic agent to prevent hearing loss during aminoglycoside therapy GLESER, MALCOLM ORICULA THERAPEUTICS, LLC WA $1,116,932
Tuberculosis 2017 NHLBI 5R01HL130192-02 SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial CATTAMANCHI, ADITHYA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $641,495
Tuberculosis 2017 NIAID 5R01AI116155-03 Pharmacometric optimization of second line drugs for MDR tuberculosis treatment MCILLERON, HELEN UNIVERSITY OF CAPE TOWN SO AFR $245,442
Tuberculosis 2017 NIAID 5R21AI123753-02 The splicing factor SF3b1 is a master regulator of the innate immune response to Mycobacterium tuberculosis WATSON, ROBERT TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $185,625
Tuberculosis 2017 NIAID 5R01AI057460-13 The Role of Group 1 CD1-restricted T Cells in Infectious Disease WANG, CHYUNG-RU NORTHWESTERN UNIVERSITY AT CHICAGO IL $457,664
Tuberculosis 2017 NIAID 5R01AI116604-03 Role of Tuberculosinyl Metabolites in M. Tuberculosis Virulence MOODY, DAVID BRIGHAM AND WOMEN'S HOSPITAL MA $443,750
Tuberculosis 2017 NIAID 5R21AI122001-02 A Clinical Pharmacology Study of a Novel Drug Regimen for Pre XDR and XDR Tuberculosis KEMPKER, RUSSELL EMORY UNIVERSITY GA $193,545
Tuberculosis 2017 FIC 5D43TW009522-03 TB/MDR-TB Research Capacity Building in LMIC in Southeast Asia CHONGSUVIVATWONG, VIRASAKDI PRINCE OF SONGKLA UNIVERSITY THAIL $215,921
Tuberculosis 2017 NIAID 5R01AI097494-05 The Impact of Diabetes on TB treatment outcomes GOLUB, JONATHAN JOHNS HOPKINS UNIVERSITY MD $626,943
Tuberculosis 2017 NIAID 5K24AI104830-03 Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics DORMAN, SUSAN JOHNS HOPKINS UNIVERSITY MD $83,934
Tuberculosis 2017 NIAID 5R01AI105422-05 An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine FLYNN, JOANNE UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $1,133,663
Tuberculosis 2017 NIAID 5U01AI115594-03 Diagnostics and Pharmacotherapy for Severe Forms of TB HEYSELL, SCOTT UNIVERSITY OF VIRGINIA VA $657,815
Tuberculosis 2017 NIAID 5R21AI122922-02 A novel "shock and kill" strategy for eliminating Mtb persisters in the CD4 T-cell-deficient host KARAKOUSIS, PETROS JOHNS HOPKINS UNIVERSITY MD $202,500
Tuberculosis 2017 NIGMS 1SC2AI133653-01 Using Psidin to Study the Regulation of Phagocytosis vs Autophagy Pathways BRENNAN, CATHERINE CALIFORNIA STATE UNIVERSITY FULLERTON CA $139,100
Tuberculosis 2017 NIAID 5R01AI104589-05 TB Surrogate Markers for Assessing Reponse to Treatment (TB SMART Study) NAHID, PAYAM UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $1,142,366
Tuberculosis 2017 NIAID 5R01AI117023-02 The role of Ser/Thr/Tyr phosphosignaling in the M. tuberculosis latency switch GRUNDNER, CHRISTOPH SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $482,505
Tuberculosis 2017 NIAID 5R01AI123433-02 Inhibition of MEP pathway Isoprenoid Biosynthesis DOWD, CYNTHIA GEORGE WASHINGTON UNIVERSITY DC $513,396
Tuberculosis 2017 NIAID 5K01AI118559-03 The effect of mixed-strain M. tuberculosis infections on treatment outcomes SHIN, SANGHYUK UNIVERSITY OF CALIFORNIA LOS ANGELES CA $38,871
Tuberculosis 2017 NIAID 5K23AI118592-03 Childhood Tuberculosis Infection Among School-Age Children in Rural Uganda MARQUEZ, CARINA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $194,381
Tuberculosis 2017 NIAID 5U19AI111224-03 7567 A multi-disciplinary approach to the identification of host metabolic determinan MURRAY, MEGAN BRIGHAM AND WOMEN'S HOSPITAL MA $377,662
Tuberculosis 2017 NIAID 5U19AI111224-03 7568 Identify the host genetic determinants of immune response and TB countrol RAYCHAUDHURI, SOUMYA BRIGHAM AND WOMEN'S HOSPITAL MA $259,788
Tuberculosis 2017 NIAID 5U19AI111224-03 7569 Measure the metabolic and genetic factors that determine M. Tuberculosis MOODY, DAVID BRIGHAM AND WOMEN'S HOSPITAL MA $532,144
Tuberculosis 2017 NIAID 5U19AI111224-03 7571 Administrative Core MOODY, DAVID BRIGHAM AND WOMEN'S HOSPITAL MA $296,850
Tuberculosis 2017 NIAID 5U19AI111224-03 7572 Human Subjects Core MURRAY, MEGAN BRIGHAM AND WOMEN'S HOSPITAL MA $466,495
Tuberculosis 2017 NIAID 5U19AI111224-03 7573 Bioinformatics Core RAYCHAUDHURI, SOUMYA BRIGHAM AND WOMEN'S HOSPITAL MA $333,292
Tuberculosis 2017 NIAID 5U19AI111224-03 7574 Animal Models Core RAYCHAUDHURI, SOUMYA BRIGHAM AND WOMEN'S HOSPITAL MA $563,789
Tuberculosis 2017 NIAID 5U19AI111224-03 7575 Metabolomics Core MOODY, DAVID BRIGHAM AND WOMEN'S HOSPITAL MA $214,474
Tuberculosis 2017 NIAID 5R01AI123146-02 The impact of pyrazinamide on metabolism in Mycobacterium tuberculosis. BAUGHN, ANTHONY UNIVERSITY OF MINNESOTA MN $381,458
Tuberculosis 2017 NIAID 5R21AI119573-02 Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis. BERNEY, MICHAEL ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $208,750
Tuberculosis 2017 NIAID 1R01AI127711-01 Modulation of Host Cell Environment by Mycobacterial PE/PPE Proteins LEE, SUNHEE DUKE UNIVERSITY NC $570,209
Tuberculosis 2017 NIGMS 1R01GM121780-01 Using Small Compounds as Probes for Studying Mechanosensitive Channel Gating BLOUNT, PAUL UT SOUTHWESTERN MEDICAL CENTER TX $131,437
Tuberculosis 2017 NIAID 1R01AI127724-01 Development of Selective Ribosomal P-site Inhibitors LOOPER, RYAN UNIVERSITY OF UTAH UT $378,021
Tuberculosis 2017 NIAID 1R01AI128215-01 A systems analysis of drug tolerance in Mycobacterium tuberculosis BALIGA, NITIN INSTITUTE FOR SYSTEMS BIOLOGY WA $871,572
Tuberculosis 2017 NIAID 5U01AI115619-03 Biology and Biosignatures of Anti-Tuberculosis Treatment Response BELISLE, JOHN COLORADO STATE UNIVERSITY CO $585,300
Tuberculosis 2017 NIAID 5K08AI116908-03 The role of mycobacterial efflux pumps in virulence and antibiotic tolerance HERNANDEZ, RAFAEL SEATTLE CHILDREN'S HOSPITAL WA $176,644
Tuberculosis 2017 NIAID 5R33AI105977-05 Discovery of marine natural products targeting latent M. tuberculosis ROHDE, KYLE UNIVERSITY OF CENTRAL FLORIDA FL $442,200
Tuberculosis 2017 NIAID 5U01AI116392-03 Cell Phone Video Directly Observed Therapy to Monitor Short Course LTBI Treatment GARFEIN, RICHARD UNIVERSITY OF CALIFORNIA SAN DIEGO CA $628,162
Tuberculosis 2017 NIAID 5R01AI123286-02 Tuberculosis and T cell Recognition BEHAR, SAMUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $698,256
Tuberculosis 2017 NIAID 5R01AI123093-02 Predicting protective T-cell responses in Tuberculosis using a systems biology approach KIRSCHNER, DENISE UNIVERSITY OF MICHIGAN MI $735,488
Tuberculosis 2017 NIAID 5R01AI111871-04 HIV-TB Co-infection: Tracking TB emergence after asymptomatic (latent) infection LIN, PHILANA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $676,755
Tuberculosis 2017 NIAID 5R01AI111992-04 Integrative Pharmacology Approach to Understand Mechanisms of TB Drug Resistance NUERMBERGER, ERIC JOHNS HOPKINS UNIVERSITY MD $748,871
Tuberculosis 2017 NIAID 1K08AI127908-01 Translational modeling of individual- and population-level outcomes of novel tuberculosis drug regimens KENDALL, EMILY JOHNS HOPKINS UNIVERSITY MD $194,681
Tuberculosis 2017 NIAID 5R01AI104817-05 HOST AND MICROBIOLOGICAL DETERMINANTS OF INFECTIOUSNESS IN PATIENTS WITH DRUG SEN DHEDA, KEERTAN UNIVERSITY OF CAPE TOWN SO AFR $132,686
Tuberculosis 2017 NIDCR 5R01DE025015-03 Post-translocational protein folding in Gram-positive bacteria TON-THAT, HUNG UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $390,071
Tuberculosis 2017 NIAID 1R21AI128082-01 Exploitation of mycobacteriophage-encoded partitioning cassettes HATFULL, GRAHAM UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $231,938
Tuberculosis 2017 NIAID 5R33AI105944-05 Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy KRAMNIK, IGOR BOSTON UNIVERSITY MEDICAL CAMPUS MA $491,100
Tuberculosis 2017 FIC 5D43TW009539-05 HIV Implementation Science Research Training Program REINGOLD, ARTHUR UNIVERSITY OF CALIFORNIA BERKELEY CA $272,824
Tuberculosis 2017 FIC 5D43TW009573-05 Tuberculosis Research Institute at MUHAS VON REYN, C. DARTMOUTH COLLEGE NH $269,658
Tuberculosis 2017 NIAID 1R03AI128132-01 Mutations that Confer Mycobacteria Resistance to Carbapenems LAMICHHANE, GYANU JOHNS HOPKINS UNIVERSITY MD $81,604
Tuberculosis 2017 NIAID 5R21AI123970-02 Manganese acquisition and Mycobacterium tuberculosis virulence RODRIGUEZ, GLORIA RBHS-NEW JERSEY MEDICAL SCHOOL NJ $198,750
Tuberculosis 2017 NIAID 5R01AI120694-03 Discovery of novel, ubiquitin-regulated mechanisms of TB control by macrophages KROGAN, NEVAN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $725,970
Tuberculosis 2017 NIAID 5R01AI026170-30 Molecular Genetic Analysis of Mycobacterium tuberculosis JACOBS, WILLIAM ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $576,342
Tuberculosis 2017 NIAID 5R33AI105807-05 Targeting the Host to Treat TB: Inhibitors of Protein Kinase R NATHAN, CARL WEILL MEDICAL COLL OF CORNELL UNIV NY $364,370
Tuberculosis 2017 NIAID 5R01AI117929-02 Immune control mechanisms of TB latency in the setting of HIV co-infection GOLDFELD, ANNE BOSTON CHILDREN'S HOSPITAL MA $442,500
Tuberculosis 2017 NIDDK 5R01DK098075-05 Trial of Vitamin D in HIV Progression FAWZI, WAFAIE HARVARD SCHOOL OF PUBLIC HEALTH MA $508,245
Tuberculosis 2017 NIAID 4R37AI054503-15 Host responses to Mycobacterium infection in Zebrafish. RAMAKRISHNAN, LALITA UNIVERSITY OF CAMBRIDGE UK $270,000
Tuberculosis 2017 NIAID 5R21AI121548-02 Synthesis and Studies of a New Family of Antibiotics NOWICK, JAMES UNIVERSITY OF CALIFORNIA-IRVINE CA $173,486
Tuberculosis 2017 NIAID 5R03AI122067-02 The Effects of M. tuberculosisInfection on Lung Microbiome in Macaques FLYNN, JOANNE UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $77,968
Tuberculosis 2017 NIAID 5U19AI109725-04 8415 Autophagy-Inducting Peptides and Target Identification for Treatment of Viruses LEVINE, BETH WASHINGTON UNIVERSITY MO $1,748,997
Tuberculosis 2017 NIAID 5R01AI121144-02 Improving the molecular diagnosis of drug resistant tuberculosis KATO-MAEDA, MIDORI UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $709,614
Tuberculosis 2017 NIAID 5R01AI049151-11 Menaquinone Biosynthesis: A Drug Target in Gram-Positive Bacteria CRICK, DEAN COLORADO STATE UNIVERSITY CO $419,611
Tuberculosis 2017 FIC 5D43TW007124-13 Emory-Georgia TB Research Training Program BLUMBERG, HENRY EMORY UNIVERSITY GA $267,672
Tuberculosis 2017 NIAID 5R01AI049313-17 T cell Responses to CD1-restricted Lipids in Tuberculosis MOODY, DAVID BRIGHAM AND WOMEN'S HOSPITAL MA $425,337
Tuberculosis 2017 NIAID 5U19AI109755-04 8165 Genetic determinants of drug resistance in Mycobacteria tuberculosis MURRAY, MEGAN HARVARD MEDICAL SCHOOL MA $913,254
Tuberculosis 2017 NIAID 5U19AI109755-04 8166 Innovative Strategies to Improve Tuberculosis Diagnostics in Children FRANKE, MOLLY HARVARD MEDICAL SCHOOL MA $1,095,803
Tuberculosis 2017 NIAID 5U19AI109755-04 8167 Discovery and validation of drug resistance mutations RUBIN, ERIC HARVARD MEDICAL SCHOOL MA $734,112
Tuberculosis 2017 NIAID 5U19AI109755-04 8168 Integrated system for Category C infectious disease diagnostics in resource-limi CHANDLER, DARRELL AKONNI BIOSYSTEMS, INC. MD $2,182,203
Tuberculosis 2017 NIAID 5U19AI109755-04 8169 Administrative Core MURRAY, MEGAN HARVARD MEDICAL SCHOOL MA $616,132
Tuberculosis 2017 NIAID 5U19AI109755-04 8170 Sequencing Core SACCHETTINI, JAMES TEXAS A&M UNIVERSITY TX $408,777
Tuberculosis 2017 NIAID 5R01AI111935-04 Autophagy Against Tuberculosis and HIV DERETIC, VOJO UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $658,214
Tuberculosis 2017 NHLBI 5R01HL105427-07 ROLE OF IL-17 IN PROTECTIVE VACCINE-INDUCED IMMUNE RESPONSES AGAINST TUBERCULOSIS KHADER, SHABAANA WASHINGTON UNIVERSITY MO $426,417
Tuberculosis 2017 NIAID 5R01AI104960-04 Application of Imaging to Development of Tuberculosis Interventions CIRILLO, JEFFREY TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $371,800
Tuberculosis 2017 FIC 5D43TW009127-05 Ethiopia-Emory TB Research Training Program BLUMBERG, HENRY EMORY UNIVERSITY GA $251,497
Tuberculosis 2017 FIC 5D43TW009574-05 HIV-TB Fogarty Research Training Program BOLLINGER, ROBERT JOHNS HOPKINS UNIVERSITY MD $255,537
Tuberculosis 2017 NIAID 1R01AI123148-01A1 Metabolite modulation of Mtb regulators of cell wall biogenesis PURDY, GEORGIANA OREGON HEALTH & SCIENCE UNIVERSITY OR $495,146
Tuberculosis 2017 NIAID 5K23AI125122-02 Pharmacokinetic and Programmatic Evaluations to Optimize HIV/TB Co-Treatment Regimens in Children RAWIZZA, HOLLY BRIGHAM AND WOMEN'S HOSPITAL MA $199,549
Tuberculosis 2017 NIAID 5R01AI112748-03 Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission NARDELL, EDWARD BRIGHAM AND WOMEN'S HOSPITAL MA $692,241
Tuberculosis 2017 NIAID 5R21AI121099-02 Novel vaccine boosting candidates for tuberculosis ORME, IAN COLORADO STATE UNIVERSITY CO $227,500
Tuberculosis 2017 NIAID 5R21AI117688-02 Identification of ID93+GLA-SE biomarkers for prevention of recurrent TB COLER, RHEA INFECTIOUS DISEASE RESEARCH INSTITUTE WA $133,950
Tuberculosis 2017 NHLBI 5R01HL092774-10 Virulence Regulation by the Mycobacterium tuberculosis Proteasome DARWIN, KATERINA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $423,750
Tuberculosis 2017 NHLBI 5R01HL127384-02 Determinants of Tuberculosis Severity KORNFELD, HARDY UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $548,586
Tuberculosis 2017 NIAID 1R01AI123310-01A1 IFN-γ independent inhibition of MTB growth in human macrophages VANKAYALAPATI, RAMAKRISHNA UNIVERSITY OF TEXAS HLTH CTR AT TYLER TX $360,800
Tuberculosis 2017 NHLBI 5R01HL128778-02 Innate immunity of granulomatous inflammation: the role of VEGF SANDOR, MATYAS UNIVERSITY OF WISCONSIN-MADISON WI $382,500
Tuberculosis 2017 NIAID 5R33AI111647-04 Discovery and Validation of Drug Targets in Vulnerable Populations ALLAND, DAVID RBHS-NEW JERSEY MEDICAL SCHOOL NJ $478,857
Tuberculosis 2017 NIAID 1R44AI128777-01 Combining faster detection with ID: a new paradigm for mycobacterial culture RHODES, PAUL SPECIFIC TECHNOLOGIES, LLC FL $1,000,000
Tuberculosis 2017 NIAID 5R33AI111739-04 Development of an Oral Carbapenem Drug for Treatment of Drug Resistant TB LAMICHHANE, GYANU JOHNS HOPKINS UNIVERSITY MD $478,053
Tuberculosis 2017 NICHD 5R01HD083047-03 Optimizing and operationalizing pediatric drug-resistant tuberculosis treatment GARCIA-PRATS, ANTHONY STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS SO AFR $75,969
Tuberculosis 2017 NIAID 5R33AI111696-04 Targeting a New Essential Virulence Mechanism in Drug-Resistant Mycobacteria STALLINGS, CHRISTINA WASHINGTON UNIVERSITY MO $459,801
Tuberculosis 2017 NIAID 5R01AI119122-03 Exploiting metabolic toxicities to identify compounds that inhibit cholesterol metabolism in M. Tuberculosis VANDERVEN, BRIAN CORNELL UNIVERSITY NY $387,500
Tuberculosis 2017 NCI 5R01AI122932-03 Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring HU, YE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $20,693
Tuberculosis 2017 NIAID 5R01AI122932-03 Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring HU, YE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $389,849
Tuberculosis 2017 NIBIB 5R01AI122932-03 Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring HU, YE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $14,366
Tuberculosis 2017 NINDS 5R01AI122932-03 Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring HU, YE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $53,546
Tuberculosis 2017 OD 5R01AI122932-03 Quantification of Circulating Antigens for Pediatric TB Diagnosis andTreatment Monitoring HU, YE ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $13,260
Tuberculosis 2017 NIAID 5R01AI042999-20 Pattern Recognition Receptors and Autophagy in Mtb Control in AIDS DERETIC, VOJO UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR NM $399,999
Tuberculosis 2017 NIAID 5R01AI048391-11 Role of gamma/delta T cells in Vaccine Induced Immunity HOFT, DANIEL SAINT LOUIS UNIVERSITY MO $782,578
Tuberculosis 2017 NIAID 5R01AI111815-03 The Impact of Pre-exisiting SIV on Host Immunity to M tuberculosis in Macaques SCANGA, CHARLES UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $757,751
Tuberculosis 2017 NIAID 5R21AI109293-02 Role of the alternative ribosomes in Mycobacterium tuberculosis adaptation PRISIC, SLADJANA UNIVERSITY OF HAWAII AT MANOA HI $176,875
Tuberculosis 2017 NIAID 1R01AI128765-01 Validation of Biomarkers of Pediatric TB and further development for use in diagnosis of childhood TB LEVIN, MICHAEL U OF L IMPERIAL COL OF SCI/TECHNLGY/MED UK $1,001,605
Tuberculosis 2017 NIAID 1R21AI123501-01A1 Mechanism-based targeting of bacterial topoisomerases MAIZELS, NANCY UNIVERSITY OF WASHINGTON WA $214,986
Tuberculosis 2017 NIA 5P01AG051428-02 7472 Biology of the human lung mucosa in aging and tuberculosis TORRELLES, JORDI OHIO STATE UNIVERSITY OH $294,202
Tuberculosis 2017 NIA 5P01AG051428-02 7473 Biology of alveolar macrophages in aging and tuberculosis SCHLESINGER, LARRY OHIO STATE UNIVERSITY OH $285,742
Tuberculosis 2017 NIA 5P01AG051428-02 7474 Defining age-associated immune correlates of susceptibility to M. tuberculosis TURNER, JOANNE OHIO STATE UNIVERSITY OH $366,494
Tuberculosis 2017 NIA 5P01AG051428-02 7475 Defining immune correlates of susceptibility to M. tuberculosis infection in the elderly WANG, SHU-HUA OHIO STATE UNIVERSITY OH $269,847
Tuberculosis 2017 NIGMS 5R01GM114450-03 Structure/function analyses of essential mycobacterial transcription regulators CAMPBELL, ELIZABETH ROCKEFELLER UNIVERSITY NY $369,885
Tuberculosis 2017 NIAID 5U19AI109713-04 8683 Process and pathway based discovery of novel anti-TB drugs ALLAND, DAVID RBHS-NEW JERSEY MEDICAL SCHOOL NJ $493,771
Tuberculosis 2017 NIAID 5U19AI109713-04 8685 Bayesian models to accelerate antibacterial drug discovery FREUNDLICH, JOEL RBHS-NEW JERSEY MEDICAL SCHOOL NJ $429,294
Tuberculosis 2017 NIAID 5U19AI109713-04 8688 Animal Model Core PERLIN, DAVID RBHS-NEW JERSEY MEDICAL SCHOOL NJ $698,460
Tuberculosis 2017 NIAID 1R21AI123859-01A1 Remodeling of ribosome function by MazF toxins WOYCHIK, NANCY RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL NJ $266,750
Tuberculosis 2017 NIAID 5R01AI111940-03 Heme oxygenase-1 and the bioenergetic threshold of latent TB and HIV co-infection STEYN, ADRIE UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $335,520
Tuberculosis 2017 NIAID 1R21AI123876-01A1 Development of a method for visual detection of Mycobacterium tuberculosis complex GERASIMOVA, YULIA UNIVERSITY OF CENTRAL FLORIDA FL $205,317
Tuberculosis 2017 NIAID 1R21AI124225-01A1 Defining the role of host lipid repertoire in Mycobacterium tuberculosis infection TAFESSE, FIKADU OREGON HEALTH & SCIENCE UNIVERSITY OR $192,500
Tuberculosis 2017 NIAID 1R01AI128862-01 Biosynthesis and medicinal chemistry of the capuramycin antimycobacterial antibiotics VAN LANEN, STEVEN UNIVERSITY OF KENTUCKY KY $200,000
Tuberculosis 2017 NIAID 5R01AI119178-03 Membrane Protein Structures and Interactions in the M. tuberculosis Divisome CROSS, TIMOTHY FLORIDA STATE UNIVERSITY FL $731,754
Tuberculosis 2017 NIAID 5R37AI095983-07 Genome-Wide Dissection of Mendelian Susceptibility to Mycobacterial Disease CASANOVA, JEAN-LAURENT ROCKEFELLER UNIVERSITY NY $423,750
Tuberculosis 2017 NIAID 5U01AI115940-03 Inflammatory determinants of disease severity and treatment outcome in TB patients WILKINSON, ROBERT UNIVERSITY OF CAPE TOWN SO AFR $162,700
Tuberculosis 2017 NIAID 5R33AI105936-05 A "radical" approach to tuberculosis infection HUNG, DEBORAH BROAD INSTITUTE, INC. MA $549,000
Tuberculosis 2017 NIAID 5R01AI111397-04 Pre-clinical Development of an Advanced Genexpert Test for Drug Resistant Mtb ALLAND, DAVID RBHS-NEW JERSEY MEDICAL SCHOOL NJ $1,134,247
Tuberculosis 2017 NIAID 5R01AI113270-03 Metabolic regulation of macrophage function during M. tuberculosis infection STANLEY, SARAH UNIVERSITY OF CALIFORNIA BERKELEY CA $378,443
Tuberculosis 2017 NIAID 5R01AI111914-03 ROLE OF INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE IN LATENT TUBERCULOSIS KHADER, SHABAANA WASHINGTON UNIVERSITY MO $877,406
Tuberculosis 2017 NIAID 5R01AI111967-04 De facto monotherapy during multidrug TB treatment and emergence of resistance DARTOIS, VERONIQUE RBHS-NEW JERSEY MEDICAL SCHOOL NJ $788,371
Tuberculosis 2017 FIC 5D43TW009588-04 Research Training on Pathogenesis and Diagnosis of HIV-TB LAAL, SUMAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $304,400
Tuberculosis 2017 NIAID 5R01AI111948-04 NK cell-mediated regulation of T cell immunity in TB/HIV co-infection DAY, CHERYL EMORY UNIVERSITY GA $818,412
Tuberculosis 2017 NIAID 5U19AI110818-04 6826 Genomics of bacterial pathogens: host response, persistence and transmission EARL, ASHLEE BROAD INSTITUTE, INC. MA $1,030,859
Tuberculosis 2017 NIAID 2R42AI117990-02 Lactoferrin Modulation of Granuloma Pathology ACTOR, JEFFREY PHARMAREVIEW CORPORATION TX $815,321
Tuberculosis 2017 FIC 5D43TW009771-04 HIV Co-infections in Uganda: TB, Cryptococcus, and Viral Hepatitis. MANABE, YUKARI JOHNS HOPKINS UNIVERSITY MD $289,221
Tuberculosis 2017 NIAID 1F32AI124658-01A1 Role of Developmental Signaling Pathways in Tuberculosis Pathogenesis ROSENBERG, ALLISON DUKE UNIVERSITY NC $7,725
Tuberculosis 2017 FIC 5D43TW010350-02 HIV and Mycobacterial Disease in Mali MURPHY, ROBERT NORTHWESTERN UNIVERSITY AT CHICAGO IL $303,893
Tuberculosis 2017 NIAID 1F31AI129359-01 Investigating a fluorogenic DMN-trehalose conjugate as a novel detection tool for Mycobacterium tuberculosis KAMARIZA, MIREILLE STANFORD UNIVERSITY CA $44,044
Tuberculosis 2017 NIAID 5K01AI119603-02 Improving the control of multidrug-resistant tuberculosis through targeted screening and use of novel anti-tuberculosis drugs YAESOUBI, REZA YALE UNIVERSITY CT $129,444
Tuberculosis 2017 NIAID 1R01AI129411-01 Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis DORMAN, SUSAN JOHNS HOPKINS UNIVERSITY MD $1,424,115
Tuberculosis 2017 NIAID 5R01AI119037-02 The impact of alcohol consumption on TB treatment outcomes JACOBSON, KAREN BOSTON MEDICAL CENTER MA $636,004
Tuberculosis 2017 NIAID 1R21AI118351-01A1 Role of M. tuberculosis error-prone DNA polymerase DnaE2 in mutagenesis and drug resistance MCDONOUGH, KATHLEEN WADSWORTH CENTER NY $249,398
Tuberculosis 2017 NIAID 5R01AI106872-05 Role of N-alpha acetylation in mycobacterial secretion and virulence CHAMPION, PATRICIA UNIVERSITY OF NOTRE DAME IN $380,000
Tuberculosis 2017 NIAID 5K23AI120793-02 Impact of maternal HIV on Mycobacterium tuberculosis infection among peripartum women and their infants LACOURSE, SYLVIA UNIVERSITY OF WASHINGTON WA $184,588
Tuberculosis 2017 NHLBI 5R01HL081149-11 Impact of Diabetes and Hyperlipidemia on Host Defense KORNFELD, HARDY UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $418,750
Tuberculosis 2017 NIAID 5R01AI064282-10 Tuberculosis Pathogenesis and Drug Response SASSETTI, CHRISTOPHER UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $418,750
Tuberculosis 2017 NIAID 5R01AI060899-15 Bacterial N-Acetyltransferases: Resistance to Regulation BLANCHARD, JOHN ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $547,907
Tuberculosis 2017 NIAID 5R01AI110386-04 Host-Pathogen Interactions in a Failing Global lineage of MTBC:M.africanum DIALLO, SOULEYMANE UNIV OF SCIENCES, TECH & TECH OF BAMAKO MALI $151,526
Tuberculosis 2017 NHLBI 5R01HL126066-02 Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies KRAMNIK, IGOR BOSTON UNIVERSITY MEDICAL CAMPUS MA $711,270
Tuberculosis 2017 NIGMS 5R01GM079759-07 Computational Annotation of Orphan Metabolic Activities VITKUP, DENNIS COLUMBIA UNIVERSITY HEALTH SCIENCES NY $488,385
Tuberculosis 2017 NIGMS 5R01GM101988-39 Sequence Determinants of Protein Structure and Stability SAUER, ROBERT MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $430,141
Tuberculosis 2017 NIEHS 5R21ES026383-02 Mycobacterium tuberculosis-manganese interactions and neurotoxicity FILIPOV, NIKOLAY UNIVERSITY OF GEORGIA GA $187,500
Tuberculosis 2017 NIAID 5R01AI125160-02 Immunotherapy to prevent drug-resistant tuberculosis COLER, RHEA INFECTIOUS DISEASE RESEARCH INSTITUTE WA $1,314,028
Tuberculosis 2017 NIAID 5R01AI114900-04 Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence LARSEN, MICHELLE ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $633,748
Tuberculosis 2017 NCI 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $260,000
Tuberculosis 2017 NIAID 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $1,309,336
Tuberculosis 2017 NICHD 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $325,000
Tuberculosis 2017 NIDA 5U01AI069907-12 IeDEA Asia-Pacific Research Collaboration SOHN, ANNETTE FOUNDATION FOR AIDS RESEARCH NY $100,000
Tuberculosis 2017 FIC 5D71TW010337-02 Strengthening Ugandan Biomedical Engineering HIV/TB Human Resource Research Capacity JOLOBA, MOSES MAKERERE UNIVERSITY UGANDA $28,166
Tuberculosis 2017 NIAID 2R13AI084562-07 Infectious Diseases in Africa: Immune Escape and HIV Vaccines FERRARI, GUIDO DUKE UNIVERSITY NC $48,401
Tuberculosis 2017 NIAID 1R01AI125000-01A1 Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden HAVLIR, DIANE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $724,208
Tuberculosis 2017 NIAID 5R01AI064693-12 Mechanisms of Mycobacterial DNA Repair and Mutagenesis GLICKMAN, MICHAEL SLOAN-KETTERING INST CAN RESEARCH NY $549,818
Tuberculosis 2017 NIAID 5R01AI106733-05 Disrupting Biofilm Formation to Improve TB Drug Treatment BASARABA, RANDALL COLORADO STATE UNIVERSITY CO $363,261
Tuberculosis 2017 NIAID 1R01AI129708-01 Active_Case_Finding_Testing_and_Linkage_to_Treatment_and_Improved_Survival_(ACTTIS)_Study MARTINSON, NEIL WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $542,244
Tuberculosis 2017 NICHD 5U01HD085531-03 Replisome dynamics in M tuberculosis_linking persistence to genetic resistance WARNER, DIGBY UNIVERSITY OF CAPE TOWN SO AFR $142,233
Tuberculosis 2017 NIAID 5R01AI097302-05 CRAC Channel Deficiency in Immunity to Infection FESKE, STEFAN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $486,036
Tuberculosis 2017 NIAID 5K01AI104351-04 Preventing Childhood Tuberculosis in Lesotho (PREVENT Study) HIRSCH-MOVERMAN, YAEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $127,788
Tuberculosis 2017 FIC 5D43TW010062-03 Research Training Program in the Diagnosis, Treatment, and Prevention of AIDS-related MDR-TB in Haiti FITZGERALD, DANIEL WEILL MEDICAL COLL OF CORNELL UNIV NY $290,035
Tuberculosis 2017 NIAID 5R01AI113287-03 Drifting to victory: resolving the paradox of M.tuberculosis evolution PEPPERELL, CAITLIN UNIVERSITY OF WISCONSIN-MADISON WI $374,020
Tuberculosis 2017 OD 5K01OD016997-04 Mechanisms of Diabetic Susceptibility to Tuberculosis PODELL, BRENDAN COLORADO STATE UNIVERSITY CO $123,093
Tuberculosis 2017 FIC 5D43TW010039-03 Pitt HIV-TB research and training program in India GUPTA, PHALGUNI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $299,728
Tuberculosis 2017 OD 1S10OD023524-01 A QTRAP 6500 LC-MS/MS System from SCIEX for high accuracy drug content analysis DARTOIS, VERONIQUE RBHS-NEW JERSEY MEDICAL SCHOOL NJ $526,083
Tuberculosis 2017 NIAID 5R01AI104824-05 Mobile Health for Implementation of Home-based TB Contact Investigation in Uganda DAVIS, JOHN YALE UNIVERSITY CT $532,316
Tuberculosis 2017 NIAID 5U19AI106761-05 6613 Host Determinants of TB Disease Progression ADEREM, ALAN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $1,074,741
Tuberculosis 2017 NIAID 5U19AI106761-05 6614 Bacterial Determinants of TB Progression SHERMAN, DAVID SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $763,150
Tuberculosis 2017 NIAID 5U19AI106761-05 6616 Technology Core ADEREM, ALAN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $889,513
Tuberculosis 2017 NIAID 5U19AI106761-05 6617 Modeling Core BALIGA, NITIN INSTITUTE FOR SYSTEMS BIOLOGY WA $582,660
Tuberculosis 2017 NIAID 5K01AI102944-06 Understanding spatial heterogeneity of drug resistant tuberculosis JENKINS, HELEN BOSTON UNIVERSITY MEDICAL CAMPUS MA $128,349
Tuberculosis 2017 NIGMS 5R01GM065440-14 Spectroscopy of Fe-S Cluster Proteins CRAMER, STEPHEN UNIVERSITY OF CALIFORNIA AT DAVIS CA $485,291
Tuberculosis 2017 NIAID 5R01AI116525-03 MmpL3 as a target for novel anti-TB agents JACKSON, MARY COLORADO STATE UNIVERSITY CO $513,570
Tuberculosis 2017 NIAID 5R01AI095041-05 Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil GOLUB, JONATHAN JOHNS HOPKINS UNIVERSITY MD $562,393
Tuberculosis 2017 NIAID 5R01AI120821-03 Rapid Immune Restoration and Lung Injury in HIV/TB BISSON, GREGORY UNIVERSITY OF PENNSYLVANIA PA $618,851
Tuberculosis 2017 NIAID 5F32AI120556-03 Defining the Impact of Neutrophils on Bacterial Environment during Tuberculosis LOVEWELL, RUSTIN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $57,066
Tuberculosis 2017 NIAID 5K23AI102639-05 Rifampicin Malabsorption in HIV+ Patients: Mechanisms and Recovery after HAART VINNARD, CHRISTOPHER RBHS-NEW JERSEY MEDICAL SCHOOL NJ $166,104
Tuberculosis 2017 NIAID 5P01AI073748-08 8635 The role of TIM-3 in regulating T cell function during tuberculosis BEHAR, SAMUEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $400,417
Tuberculosis 2017 NIAID 5R21AI126105-02 The role of lipid droplets in immunity to M. tuberculosis infection STANLEY, SARAH UNIVERSITY OF CALIFORNIA BERKELEY CA $235,500
Tuberculosis 2017 NIAID 5R01AI121212-02 Regulation of human IL12/IL23 responsiveness by IL12RB1 ROBINSON, RICHARD MEDICAL COLLEGE OF WISCONSIN WI $385,000
Tuberculosis 2017 NIGMS 2SC1GM095475-06 Membrane Interaction of Mycobacterium tuberculosis Virulence Factors SUN, JIANJUN UNIVERSITY OF TEXAS EL PASO TX $339,750
Tuberculosis 2017 NIAID 5R01AI124348-02 Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa BOOM, HENRY CASE WESTERN RESERVE UNIVERSITY OH $2,438,386
Tuberculosis 2017 NIAID 5K24AI114444-04 Mentorship and Patient-Oriented Research in Tuberculosis, HIV and Global Health GANDHI, NEEL EMORY UNIVERSITY GA $173,842
Tuberculosis 2017 NIGMS 5R35GM118157-02 Interplay of Transition Metal Homeostasis and Reactive Sulfur Species in Bacterial Pathogens GIEDROC, DAVID INDIANA UNIVERSITY BLOOMINGTON IN $583,775
Tuberculosis 2017 NCI 5U01AI069924-12 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $333,491
Tuberculosis 2017 NIAID 5U01AI069924-12 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $1,806,634
Tuberculosis 2017 NICHD 5U01AI069924-12 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $785,844
Tuberculosis 2017 NIDA 5U01AI069924-12 International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA) EGGER, MATTHIAS UNIVERSITAT BERN SWITZE $100,000
Tuberculosis 2017 NIAID 5R01AI118582-03 How does HIV lead to increased susceptibility to tuberculosis? RUSSELL, DAVID CORNELL UNIVERSITY NY $546,571
Tuberculosis 2017 NIAID 5K08AI119150-03 Molecular mechanism of T cell evasion by Mycobacterium tuberculosis PORTAL CELHAY, CYNTHIA NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $201,420
Tuberculosis 2017 NIAID 5K08AI108799-04 Calanolides as tools to find new drug targets for Mycobacterium tuberculosis SOMERSAN-KARAKAYA, SELIN WEILL MEDICAL COLL OF CORNELL UNIV NY $193,320
Tuberculosis 2017 NIAID 5R01AI056289-15 Recombinant Attenuated Salmonella Vaccines for Humans CURTISS III, ROY UNIVERSITY OF FLORIDA FL $444,683
Tuberculosis 2017 NIAID 5R01AI123780-02 COMMON IMMUNE CORRELATES OF RISK OF TB DISEASE IN ANIMAL MODELS AND HUMANS KHADER, SHABAANA WASHINGTON UNIVERSITY MO $734,575
Tuberculosis 2017 NIAID 5R37AI032042-24 Methods for Evaluating Vaccine Efficacy HALLORAN, M FRED HUTCHINSON CANCER RESEARCH CENTER WA $488,032
Tuberculosis 2017 NIAID 5R21AI126044-02 Exploration of the Mycobacterial Cell Envelope Proteome by Protein Labeling in Live Cells SEELIGER, JESSICA STATE UNIVERSITY NEW YORK STONY BROOK NY $198,646
Tuberculosis 2017 NIAID 5U19AI118626-03 6938 Administrative Core SETTE, ALESSANDRO LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $96,837
Tuberculosis 2017 NIAID 5U19AI118626-03 6939 Clinical Core VIJAYANAND, PANDURANGAN LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $183,627
123


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer